SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001019687-13-002616
Filing Date
2013-07-11
Accepted
2013-07-11 16:24:05
Documents
12
Period of Report
2013-04-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT peregrine_10k-043013.htm 10-K 1235372
2 SUBSIDIARIES OF REGISTRANT peregrine_10k-ex2100.htm EX-21 3235
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM peregrine_10k-ex2301.htm EX-23.1 2998
4 CERTIFICATION peregrine_10k-ex3101.htm EX-31.1 8331
5 CERTIFICATION peregrine_10k-ex3102.htm EX-31.2 8371
6 CERTIFICATION peregrine_10k-ex32.htm EX-32 6008
  Complete submission text file 0001019687-13-002616.txt   7231472

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE pphm-20130430.xml EX-101.INS 715317
8 XBRL SCHEMA FILE pphm-20130430.xsd EX-101.SCH 38208
9 XBRL CALCULATION FILE pphm-20130430_cal.xml EX-101.CAL 69139
10 XBRL DEFINITION FILE pphm-20130430_def.xml EX-101.DEF 67166
11 XBRL LABEL FILE pphm-20130430_lab.xml EX-101.LAB 274402
12 XBRL PRESENTATION FILE pphm-20130430_pre.xml EX-101.PRE 202891
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-K | Act: 34 | File No.: 001-32839 | Film No.: 13964157
SIC: 2834 Pharmaceutical Preparations